We further demonstrate that the CYP24A1 promoter is differentially methylated in endothelium derived from human prostate tumor and normal lesion, indicating that epigenetic alterations in CYP24A1 may play a role in determining the phenotype of tumor-associated vasculature in the prostate tumor microenvironment [38]. This evidence concerns the gene CYP24A1 and prostate neoplasm.